Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated COVID-19 Vaccine in Elderly with Chronic Bronchitis and COPD
NCT05075083Phase 4Unknown
- Sponsor
- China National Biotec Group
- Start
- Oct 2021
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by China National Biotec Group. Status: unknown.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05075083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05075083.